HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
+5.55%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.04B
AUM Growth
+$2.04B
(+17%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
11.36%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
229
New
51
Increased
105
Reduced
67
Closed
6
Top Buys
| 1 |
Micron Technology
MU
|
$14.9M |
| 2 |
UnitedHealth
UNH
|
$12.8M |
| 3 |
Johnson & Johnson
JNJ
|
$10.9M |
| 4 |
Eli Lilly
LLY
|
$10.6M |
| 5 |
Pfizer
PFE
|
$10.3M |
Top Sells
| 1 |
Intel
INTC
|
$13.1M |
| 2 |
NVIDIA
NVDA
|
$5.7M |
| 3 |
Meta Platforms (Facebook)
META
|
$5.24M |
| 4 |
Zoetis
ZTS
|
$4.42M |
| 5 |
Public Service Enterprise Group
PEG
|
$3.81M |
Sector Composition
| 1 | Healthcare | 50.78% |
| 2 | Technology | 18.45% |
| 3 | Financials | 8.11% |
| 4 | Consumer Discretionary | 5.51% |
| 5 | Communication Services | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$427B
| $64.6M | 3.17% | 416,931 +70,224 | +20% | +$10.9M |
|
|
2
UnitedHealth
UNH
$281B
| $63.9M | 3.14% | 135,306 +27,031 | +25% | +$12.8M |
|
|
3
Eli Lilly
LLY
$657B
| $54.1M | 2.65% | 157,517 +30,969 | +24% | +$10.6M |
|
4
AstraZeneca
AZN
$248B
| $53.6M | 2.63% | 772,788 +54,595 | +8% | +$3.79M |
|
5
AbbVie
ABBV
$372B
| $53.4M | 2.62% | 335,292 +36,172 | +12% | +$5.76M |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $53.2M | 2.61% | 64,757 +5,294 | +9% | +$4.35M |
|
7
Stryker
SYK
$150B
| $52.3M | 2.56% | 183,046 -11,661 | -6% | -$3.33M |
|
8
Boston Scientific
BSX
$156B
| $51.6M | 2.53% | 1,030,861 +9,345 | +0.9% | +$468K |
|
|
9
Zoetis
ZTS
$69.3B
| $51.5M | 2.53% | 309,440 -26,547 | -8% | -$4.42M |
|
10
Merck
MRK
$210B
| $51.2M | 2.51% | 481,263 +43,523 | +10% | +$4.63M |
|
11
Intuitive Surgical
ISRG
$170B
| $51.2M | 2.51% | 200,336 +20,209 | +11% | +$5.16M |
|
12
Novartis
NVS
$245B
| $50.2M | 2.46% | 545,589 +28,460 | +6% | +$2.62M |
|
13
Thermo Fisher Scientific
TMO
$186B
| $50.1M | 2.46% | 86,992 +83 | +0.1% | +$47.8K |
|
14
Amgen
AMGN
$155B
| $49.1M | 2.41% | 203,276 +35,415 | +21% | +$8.56M |
|
15
Bristol-Myers Squibb
BMY
$96B
| $48.9M | 2.4% | 705,196 +117,031 | +20% | +$8.11M |
|
16
Medtronic
MDT
$119B
| $47.9M | 2.35% | 594,280 +87,040 | +17% | +$7.02M |
|
|
17
Pfizer
PFE
$141B
| $47.7M | 2.34% | 1,169,142 +251,784 | +27% | +$10.3M |
|
18
Danaher
DHR
$147B
| $47M | 2.31% | 186,369 +11,136 | +6% | +$2.81M |
|
19
Elevance Health
ELV
$71.8B
| $45.9M | 2.25% | 99,889 +18,503 | +23% | +$8.51M |
|
20
Abbott
ABT
$231B
| $45M | 2.21% | 444,718 +9,003 | +2% | +$912K |
|
21
Microsoft
MSFT
$3.77T
| $37.7M | 1.85% | 130,692 +11,888 | +10% | +$3.43M |
|
22
Apple
AAPL
$3.45T
| $35.8M | 1.76% | 217,100 +33,418 | +18% | +$5.51M |
|
23
Alphabet (Google) Class A
GOOGL
$2.57T
| $34.7M | 1.71% | 334,968 +51,668 | +18% | +$5.36M |
|
24
Accenture
ACN
$162B
| $34.3M | 1.68% | 120,111 +18,403 | +18% | +$5.26M |
|
25
Visa
V
$683B
| $33.2M | 1.63% | 147,222 +4,439 | +3% | +$1M |
|